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The interaction of poly- and monoclonal antibodies against the L-chain of human Ig with Burkitt lymphoma EB-3 cells 
was studied using a fluorescent lipid probe, anthrylvinyl-labelled sphingomyelin, incorporated into the cell plasma mem- 
brane. Binding of the antibodies to Ig receptors on the surface was shown to induce changes in the fluorescence polariza- 
tion of the probe. The high sensitivity of the method allows one to detect less than 100 antibody molecules per cell. The 
possibility of using cells or liposomes carrying antigens and fluorescent lipids for the determination of antibodies in solu- 
tion is discussed. 
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1. INTRODUCTION 
In a previous paper [l] we proposed a new ap- 
proach for ligand-receptor interaction studies. The 
method is based on the following considerations. 
When a ligand binds to a membrane receptor, this 
is accompanied by conformational transformation 
of the receptor protein which in turn must be 
sensed by a large number of lipid molecules in the 
receptor’s environment, i.e. changes are induced in 
their packing characteristics. Such changes can be 
followed by incorporating a fluorescent lipid probe 
(anthrylvinyl-labelled sphingomyelin, ASM) into 
the target membrane and measuring the difference 
in fluorescence anisotropy or fluorescence 
polarization before and after addition of the 
ligand. Conditions under which the ligand-induced 
fluorescence anisotropy changes are proportional 
Correspondence address: L.D. Bergelson, Shemyakin Institute 
of Bioorganic Chemistry, UI. Miklukho-Maklaya 16/10, 
117871 Moscow, USSR 
Abbreviations: ASM, anthrylvinyl-labelled sphingomyelin, N- 
(12-(9-anthryl)-I l-trans-dodecenoyl)sphingosyl-l-phosphocho- 
line; Ig, immunoglobin; P, fluorescence polarization 
to the number of occupied receptor sites were for- 
mulated [2]. Using as an example the binding of 
the B-subunit of the plant toxin ricin to Burkitt 
lymphoma cells the fluorescence method was 
demonstrated to have the advantages of higher 
sensitivity and specificity in comparison with 
radioligand measurements [2]. 
Here, we examine the possibility of using the 
same fluorescence method for the detection of an- 
tibodies in solution by studying the influence of 
poly- and monoclonal antibodies against the light 
chains of human Ig on the fluorescence polariza- 
tion of Burkitt lymphoma EB-3 cells prelabelled 
with ASM. 
2. MATERIALS AND METHODS 
2.1. Fluorescence labelling and fluorescence polarizaiion 
The synthesis of ASM was described in [3]. Burkitt lym- 
phoma EB-3 cells were routinely cultivated in RPM1 medium, 
supplemented with 10% heat-inactivated fetal calf serum, 2 x 
10m3 M glutamine, 50 lU/ml penicillin and 50pg/ml strep- 
tomycin. Cells were grown at 37°C in a 5% COZ incubator. 
Prior to fluorescence labelling, cells were washed 3 times with 
PBS. The cells were resuspended in the same solution to a con- 
centration of 10’ cells/ml. An ethanolic solution of ASM was 
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added with stirring to a probe/phospholipid molar ratio of 
1: 100. Probe incorporation into cells was controlled by measur- 
ing the enhancement of fluorescence intensity. Fluorescence 
spectra were recorded with a Hitachi 650-60 spectrofluorimeter 
with thermostatted cells and quartz cuvettes (5 x 5 mm); slit 
width was 2 nm for excitation and 10 nm for emission. 
Fluorescence polarization was calculated by the processor of the 
spectrofluorimeter (cf. [4]). 
2.2. Antibodies 
Polyclonal antibodies were obtained by immunizing rabbits 
with human Ig light chains and were isolated from serum by af- 
finity chromatography as in [5]. Normal rabbit Ig was isolated 
from nonimmune serum by NazSO? precipitation with subse- 
quent chromatography on DEAE-cellulose. Hybridomas, pro- 
ducing monoclonal antibodies to light chains of human Ig, were 
obtained in the Laboratory of Immunology of the USSR Car- 
diology Research Center. Antibodies were isolated from ascites 
fluid by Na2S04 precipitation and subsequent DEAE-cellulose 
chromatography [6]. Antibodies were analysed by SDS-PAGE 
and isoelectrofocusing with LKB 2117 Multiphor. 
2.3. Binding of “‘I-anribodies io cells 
Labelling of antibodies was performed according to Bale et 
al. [7]. ‘2’1-labelled proteins had a specific activity of 0.3-0.6 x 
IO’ cpm/mg. Binding of ‘251-labelled antibodies was studied as 
in [6] with minor modification. Briefly, cells were washed with 
Hanks’ solution (Flow Labs) containing 1 mg bovine serum 
albumin (Calbiochem) per ml. The cells were resuspended in 
this solution to IO’ cells/ml and various amounts of “‘I- 
labelled antibodies were added. After 1 h incubation at 4°C the 
cells were washed and the amount of bound “‘I-antibodies was 
determined. As shown in [6], the method employed measures 
the specific binding of our antibodies to EB-3 cells. 
3. RESULTS AND DISCUSSION 
The binding to lymphoma cells of ‘251-labelled 
antibodies against the L-chain of human Ig was 
studied in detail previously [6]. The results of 
monoclonal antibody binding obtained here are 
presented as a Scatchard plot in fig.1. The 
calculated apparent association constant amount- 
ed to 1.2 x 10’ M-‘, while the number of binding 
sites per one lymphoma cell was equal to 5.4 x 105. 
For polyclonal antibodies, the association constant 
was 1.5fold lower and only about 10% of the an- 
tibodies interacted with L-chains of Ig on the lym- 
phoma cell surface. 
When poly- or monoclonal antibodies were add- 
ed to ASM-labelled lymphoma cells, the 
fluorescence polarization (P) increased, indicating 
reduction in the mobility of the probe (fig.2). The 
changes in P reached their maximal level within 
5-7 min and seemed to be induced by specific in- 
teraction of the antibodies with the surface an- 
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Fig. 1. Binding of ‘2SI-labelled monoclonal antibodies against 
human lg L-chain to Burkitt lymphoma EB-3 cells. Results are 
presented as a Scatchard plot: r, bound antibody molecules per 
cell; c, free antibody molecules, M. 
tigens because addition to the cell suspension of 
non-immune Ig from rabbit serum did not lead to 
measurable changes in P. The dose-response 
curves for poly- and monoclonal antibodies were 
similar (fig.2). In both cases, the antibody concen- 
tration causing maximal changes in P was 10e9 M. 
In order to evaluate these results we assumed that: 
(i) interaction of antibodies with Ig follows a 
bimolecular law; (ii) one antibody molecule binds 
to one receptor molecule; (iii) the changes in 
fluorescence polarization induced by antibody 
binding to Ig receptors are proportional to the 
number of binding sites occupied. 
With these conditions accepted, the changes in P 
can be used for determination of the number of 
bound antibody molecules causing maximal 
changes in P (see [2]). Since the saturation condi- 
tions for poly- and monoclonal antibodies are 
similar, the number of occupied Ig receptors must 
be almost equal. This amounts to 4.5 x lo4 
molecules/cell which is one order less than the 
value obtained from radioligand determinations. 
Apparently, occupation of a minor part of the 
antibody-binding sites on the cell surface prevents 
further increase in P. At least two explanations 
may be offered. The first is based on the assump- 
tion that the surface receptors are a heterogeneous 
population of proteins differing in either ac- 
cessibility for or affinity to antibodies and that the 
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Fig.2. Dependence of the change in fluorescence polarization of 
Burkitt lymphoma cells labelled with the fluorescent analog of 
sphingomyelin ASM on antibody concentration. AP = P - PO, 
where P and PO are respective values of the fluorescence 
polarization after and before addition of the antibodies. (0) 
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fluorescence method detects only one receptor sub- 
population (cf. [2]). Alternatively, the surface Ig 
molecules may comprise a homogeneous receptor 
population, but antibody binding to a minor part 
of the Ig molecules increases the rigidity of the 
lipid environment of the remaining Ig molecules to 
such extent that occupation of additional receptor 
sites would not have any effect on the fluidity of 
the surface domains sampled by ASM. 
Although it is difficult at the moment to com- 
pare the results of radioligand and fluorescence 
anisotropy measurements, the fluorescence 
method offers a number of advantages. A signifi- 
cant feature of the fluorescent lipid probe method 
is its high sensitivity. Here, reliable changes in P 
were observed even at an antibody concentration 
of lo-l3 M, which corresponds to approx. 100 an- 
tibody molecules or less per cell. 
Thus, the present results open up the promising 
possibility of using liposomes or cells carrying a 
certain antigen and a fluorescent lipid probe for 
detection of antibodies in solution. The sensitivity 
of the method which uses unmodified antigens, the 
simplicity and speed of the procedure requiring 
just a few minutes for one determination could 
make it an attractive tool in antibody-antigen in- 
teraction studies. 
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